Response to: "Placenta insufficiency and congenital heart defects".

Maartje C Snoep, Anouk M C Roestenburg,Monique C Haak

American journal of obstetrics & gynecology MFM(2023)

引用 0|浏览1
暂无评分
摘要
Congenital heart defects (CHD) affect around 1% of live births. In modern obstetrics, most CHD can be diagnosed in utero as long as fetal cardiac screening is done, which is a part of the mid-trimester anatomic ultrasound. In some centers, a fetal echocardiography examination can be done from the late first trimester onward.1 Prenatal diagnosis of CHD allows parental decision-making and the preparation for cardiac management after delivery. Although the survival rates for CHD have remarkably improved, they still are a leading cause of fetal/neonatal mortality due to birth defects. Response to: "Placenta insufficiency and congenital heart defects"American Journal of Obstetrics & Gynecology MFMPreviewPan and Li emphasize the importance of assessing the incidence of (1) isolated congenital heart disease (CHD) and (2) placenta insufficiency within the CHD registry PRECOR, and to relate this to cases of CHD with stillbirth. Full-Text PDF
更多
查看译文
关键词
placenta insufficiency,congenital heart defects”
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要